A Guernsey resident believes "people's enjoyment in life" is being sacrificed for the financial cost of using a drug that can ...

A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.

Eydenzelt is a vascular endothelial growth factor inhibitor referencing Eylea, which is jointly developed by Regeneron ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

Otsuka Pharmaceuticals could shell out over $400 million in total for the Asia-Pacific rights to 4D-150, which combines a ...

Nearly 7% of people living with diabetes develop diabetic macular edema, a serious eye condition that can lead to vision loss, according to the Cleveland Clinic. Treatment can be costly, with the ...

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models. Neovascularization is a condition that is caused by age ...

CHICAGO — Specialists are losing money with every intravitreal injection they administer, regardless of the drug being injected, an investigator warns. Each injection we do costs $127.74 — $1.60 for ...

Many surgeons admit that medical robots can now operate with greater precision than human specialists. However, the complex ...

Shares of Swiss drugmaker Roche fell on Thursday after sales of its new treatments for eye disease and haemophilia ...

President Trump’s plan to curb “urban disorder” could spell the end of “safe injection sites” that flout federal drug laws. The idea that local governments have to comply with federal law has, ...